GO:0006633 | fatty acid biosynthetic process | 9.17% (22/240) | 4.09 | 0.0 | 0.0 |
GO:0006325 | chromatin organization | 14.17% (34/240) | 2.89 | 0.0 | 0.0 |
GO:0016569 | covalent chromatin modification | 12.08% (29/240) | 3.07 | 0.0 | 0.0 |
GO:0016458 | gene silencing | 10.42% (25/240) | 3.24 | 0.0 | 0.0 |
GO:0016570 | histone modification | 10.83% (26/240) | 3.09 | 0.0 | 0.0 |
GO:0040029 | regulation of gene expression, epigenetic | 9.58% (23/240) | 3.25 | 0.0 | 0.0 |
GO:0006342 | chromatin silencing | 8.75% (21/240) | 3.36 | 0.0 | 0.0 |
GO:0045814 | negative regulation of gene expression, epigenetic | 8.75% (21/240) | 3.34 | 0.0 | 0.0 |
GO:0006631 | fatty acid metabolic process | 10.83% (26/240) | 2.84 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 12.92% (31/240) | 2.26 | 0.0 | 0.0 |
GO:0044728 | DNA methylation or demethylation | 7.08% (17/240) | 3.43 | 0.0 | 0.0 |
GO:0006304 | DNA modification | 7.08% (17/240) | 3.42 | 0.0 | 0.0 |
GO:0051253 | negative regulation of RNA metabolic process | 9.58% (23/240) | 2.76 | 0.0 | 0.0 |
GO:0032259 | methylation | 10.83% (26/240) | 2.55 | 0.0 | 0.0 |
GO:0043414 | macromolecule methylation | 10.83% (26/240) | 2.55 | 0.0 | 0.0 |
GO:0010629 | negative regulation of gene expression | 11.25% (27/240) | 2.49 | 0.0 | 0.0 |
GO:0045892 | negative regulation of transcription, DNA-templated | 9.58% (23/240) | 2.79 | 0.0 | 0.0 |
GO:1902679 | negative regulation of RNA biosynthetic process | 9.58% (23/240) | 2.79 | 0.0 | 0.0 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 9.58% (23/240) | 2.79 | 0.0 | 0.0 |
GO:0006305 | DNA alkylation | 7.08% (17/240) | 3.44 | 0.0 | 0.0 |
GO:0006306 | DNA methylation | 7.08% (17/240) | 3.44 | 0.0 | 0.0 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 9.58% (23/240) | 2.73 | 0.0 | 0.0 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 9.58% (23/240) | 2.73 | 0.0 | 0.0 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 9.58% (23/240) | 2.72 | 0.0 | 0.0 |
GO:0031327 | negative regulation of cellular biosynthetic process | 9.58% (23/240) | 2.7 | 0.0 | 0.0 |
GO:0009890 | negative regulation of biosynthetic process | 9.58% (23/240) | 2.68 | 0.0 | 0.0 |
GO:0010605 | negative regulation of macromolecule metabolic process | 11.25% (27/240) | 2.32 | 0.0 | 0.0 |
GO:0016571 | histone methylation | 7.92% (19/240) | 2.94 | 0.0 | 0.0 |
GO:0006479 | protein methylation | 7.92% (19/240) | 2.93 | 0.0 | 0.0 |
GO:0008213 | protein alkylation | 7.92% (19/240) | 2.93 | 0.0 | 0.0 |
GO:0031047 | gene silencing by RNA | 7.08% (17/240) | 3.12 | 0.0 | 0.0 |
GO:0018022 | peptidyl-lysine methylation | 7.08% (17/240) | 3.08 | 0.0 | 0.0 |
GO:0030422 | production of siRNA involved in RNA interference | 5.83% (14/240) | 3.53 | 0.0 | 0.0 |
GO:0009892 | negative regulation of metabolic process | 11.25% (27/240) | 2.25 | 0.0 | 0.0 |
GO:0034968 | histone lysine methylation | 7.08% (17/240) | 3.08 | 0.0 | 0.0 |
GO:0031050 | dsRNA fragmentation | 5.83% (14/240) | 3.5 | 0.0 | 0.0 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 5.83% (14/240) | 3.5 | 0.0 | 0.0 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 9.58% (23/240) | 2.49 | 0.0 | 0.0 |
GO:0009987 | cellular process | 55.83% (134/240) | 0.67 | 0.0 | 0.0 |
GO:0051567 | histone H3-K9 methylation | 6.25% (15/240) | 3.27 | 0.0 | 0.0 |
GO:0061647 | histone H3-K9 modification | 6.25% (15/240) | 3.27 | 0.0 | 0.0 |
GO:0051607 | defense response to virus | 5.83% (14/240) | 3.42 | 0.0 | 0.0 |
GO:0031324 | negative regulation of cellular metabolic process | 9.58% (23/240) | 2.44 | 0.0 | 0.0 |
GO:0009616 | virus induced gene silencing | 5.0% (12/240) | 3.78 | 0.0 | 0.0 |
GO:0052018 | modulation by symbiont of RNA levels in host | 5.0% (12/240) | 3.78 | 0.0 | 0.0 |
GO:0052249 | modulation of RNA levels in other organism involved in symbiotic interaction | 5.0% (12/240) | 3.78 | 0.0 | 0.0 |
GO:0098586 | cellular response to virus | 5.0% (12/240) | 3.76 | 0.0 | 0.0 |
GO:0000036 | acyl carrier activity | 2.5% (6/240) | 5.97 | 0.0 | 0.0 |
GO:0044620 | ACP phosphopantetheine attachment site binding | 2.5% (6/240) | 5.97 | 0.0 | 0.0 |
GO:0051192 | prosthetic group binding | 2.5% (6/240) | 5.97 | 0.0 | 0.0 |
GO:0006084 | acetyl-CoA metabolic process | 4.58% (11/240) | 3.9 | 0.0 | 0.0 |
GO:0035821 | modification of morphology or physiology of other organism | 5.0% (12/240) | 3.64 | 0.0 | 0.0 |
GO:0044003 | modification by symbiont of host morphology or physiology | 5.0% (12/240) | 3.64 | 0.0 | 0.0 |
GO:0051817 | modification of morphology or physiology of other organism involved in symbiotic interaction | 5.0% (12/240) | 3.64 | 0.0 | 0.0 |
GO:0010267 | production of ta-siRNAs involved in RNA interference | 5.0% (12/240) | 3.64 | 0.0 | 0.0 |
GO:0006637 | acyl-CoA metabolic process | 4.58% (11/240) | 3.83 | 0.0 | 0.0 |
GO:0035383 | thioester metabolic process | 4.58% (11/240) | 3.83 | 0.0 | 0.0 |
GO:0071840 | cellular component organization or biogenesis | 25.0% (60/240) | 1.21 | 0.0 | 0.0 |
GO:0016043 | cellular component organization | 23.75% (57/240) | 1.24 | 0.0 | 0.0 |
GO:0033865 | nucleoside bisphosphate metabolic process | 4.58% (11/240) | 3.75 | 0.0 | 0.0 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 4.58% (11/240) | 3.75 | 0.0 | 0.0 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 4.58% (11/240) | 3.75 | 0.0 | 0.0 |
GO:0051701 | interaction with host | 5.0% (12/240) | 3.53 | 0.0 | 0.0 |
GO:0009615 | response to virus | 5.83% (14/240) | 3.16 | 0.0 | 0.0 |
GO:0000911 | cytokinesis by cell plate formation | 5.83% (14/240) | 3.11 | 0.0 | 0.0 |
GO:0004312 | fatty acid synthase activity | 2.5% (6/240) | 5.63 | 0.0 | 0.0 |
GO:1903047 | mitotic cell cycle process | 6.25% (15/240) | 2.95 | 0.0 | 0.0 |
GO:0035196 | production of miRNAs involved in gene silencing by miRNA | 5.0% (12/240) | 3.43 | 0.0 | 0.0 |
GO:0032506 | cytokinetic process | 5.83% (14/240) | 3.08 | 0.0 | 0.0 |
GO:1902410 | mitotic cytokinetic process | 5.83% (14/240) | 3.08 | 0.0 | 0.0 |
GO:0044419 | interspecies interaction between organisms | 5.0% (12/240) | 3.4 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 44.17% (106/240) | 0.73 | 0.0 | 0.0 |
GO:0000226 | microtubule cytoskeleton organization | 6.25% (15/240) | 2.85 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 42.92% (103/240) | 0.75 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 40.42% (97/240) | 0.78 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 22.08% (53/240) | 1.21 | 0.0 | 0.0 |
GO:0051225 | spindle assembly | 3.33% (8/240) | 4.32 | 0.0 | 0.0 |
GO:0140104 | molecular carrier activity | 2.5% (6/240) | 5.26 | 0.0 | 0.0 |
GO:0007051 | spindle organization | 3.33% (8/240) | 4.26 | 0.0 | 0.0 |
GO:0018205 | peptidyl-lysine modification | 7.08% (17/240) | 2.52 | 0.0 | 0.0 |
GO:0016053 | organic acid biosynthetic process | 13.33% (32/240) | 1.66 | 0.0 | 0.0 |
GO:0046394 | carboxylic acid biosynthetic process | 13.33% (32/240) | 1.66 | 0.0 | 0.0 |
GO:0070925 | organelle assembly | 3.33% (8/240) | 4.23 | 0.0 | 0.0 |
GO:0007017 | microtubule-based process | 6.25% (15/240) | 2.74 | 0.0 | 0.0 |
GO:0072330 | monocarboxylic acid biosynthetic process | 10.42% (25/240) | 1.94 | 0.0 | 0.0 |
GO:0009532 | plastid stroma | 9.17% (22/240) | 2.11 | 0.0 | 0.0 |
GO:0009570 | chloroplast stroma | 9.17% (22/240) | 2.11 | 0.0 | 0.0 |
GO:0022402 | cell cycle process | 8.75% (21/240) | 2.15 | 0.0 | 0.0 |
GO:0032502 | developmental process | 25.83% (62/240) | 1.04 | 0.0 | 0.0 |
GO:0043412 | macromolecule modification | 18.33% (44/240) | 1.31 | 0.0 | 0.0 |
GO:0035194 | posttranscriptional gene silencing by RNA | 3.75% (9/240) | 3.73 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 45.42% (109/240) | 0.66 | 0.0 | 1e-06 |
GO:0044283 | small molecule biosynthetic process | 14.17% (34/240) | 1.51 | 0.0 | 1e-06 |
GO:0006732 | coenzyme metabolic process | 8.75% (21/240) | 2.06 | 0.0 | 1e-06 |
GO:0051726 | regulation of cell cycle | 6.25% (15/240) | 2.57 | 0.0 | 1e-06 |
GO:0048523 | negative regulation of cellular process | 10.0% (24/240) | 1.88 | 0.0 | 1e-06 |
GO:0031326 | regulation of cellular biosynthetic process | 18.33% (44/240) | 1.25 | 0.0 | 1e-06 |
GO:0016572 | histone phosphorylation | 3.33% (8/240) | 3.89 | 0.0 | 1e-06 |
GO:0016441 | posttranscriptional gene silencing | 3.75% (9/240) | 3.58 | 0.0 | 1e-06 |
GO:0046483 | heterocycle metabolic process | 22.92% (55/240) | 1.07 | 0.0 | 1e-06 |
GO:0006346 | methylation-dependent chromatin silencing | 4.17% (10/240) | 3.3 | 0.0 | 1e-06 |
GO:0018193 | peptidyl-amino acid modification | 7.08% (17/240) | 2.29 | 0.0 | 1e-06 |
GO:0010556 | regulation of macromolecule biosynthetic process | 17.92% (43/240) | 1.25 | 0.0 | 1e-06 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 17.92% (43/240) | 1.25 | 0.0 | 1e-06 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 17.92% (43/240) | 1.24 | 0.0 | 1e-06 |
GO:0007010 | cytoskeleton organization | 6.67% (16/240) | 2.34 | 0.0 | 2e-06 |
GO:0002252 | immune effector process | 5.83% (14/240) | 2.54 | 0.0 | 2e-06 |
GO:0050793 | regulation of developmental process | 10.42% (25/240) | 1.72 | 0.0 | 3e-06 |
GO:0034641 | cellular nitrogen compound metabolic process | 23.33% (56/240) | 1.01 | 0.0 | 3e-06 |
GO:0044434 | chloroplast part | 12.5% (30/240) | 1.51 | 0.0 | 3e-06 |
GO:0009889 | regulation of biosynthetic process | 18.33% (44/240) | 1.18 | 0.0 | 4e-06 |
GO:0065007 | biological regulation | 33.33% (80/240) | 0.76 | 0.0 | 5e-06 |
GO:0007267 | cell-cell signaling | 3.75% (9/240) | 3.3 | 0.0 | 5e-06 |
GO:0051171 | regulation of nitrogen compound metabolic process | 18.33% (44/240) | 1.16 | 0.0 | 5e-06 |
GO:0023052 | signaling | 3.75% (9/240) | 3.29 | 0.0 | 5e-06 |
GO:0006807 | nitrogen compound metabolic process | 32.92% (79/240) | 0.77 | 0.0 | 5e-06 |
GO:0006464 | cellular protein modification process | 15.0% (36/240) | 1.31 | 0.0 | 6e-06 |
GO:0036211 | protein modification process | 15.0% (36/240) | 1.31 | 0.0 | 6e-06 |
GO:0016747 | transferase activity, transferring acyl groups other than amino-acyl groups | 4.17% (10/240) | 3.04 | 0.0 | 6e-06 |
GO:0010468 | regulation of gene expression | 17.92% (43/240) | 1.17 | 0.0 | 6e-06 |
GO:0044435 | plastid part | 12.5% (30/240) | 1.47 | 0.0 | 6e-06 |
GO:0044464 | cell part | 89.58% (215/240) | 0.21 | 0.0 | 6e-06 |
GO:0008610 | lipid biosynthetic process | 10.83% (26/240) | 1.61 | 1e-06 | 6e-06 |
GO:0048519 | negative regulation of biological process | 12.08% (29/240) | 1.49 | 1e-06 | 6e-06 |
GO:0060255 | regulation of macromolecule metabolic process | 18.75% (45/240) | 1.11 | 1e-06 | 8e-06 |
GO:0050789 | regulation of biological process | 29.58% (71/240) | 0.81 | 1e-06 | 9e-06 |
GO:0080090 | regulation of primary metabolic process | 18.75% (45/240) | 1.1 | 1e-06 | 9e-06 |
GO:0006790 | sulfur compound metabolic process | 8.75% (21/240) | 1.78 | 1e-06 | 1.2e-05 |
GO:0006355 | regulation of transcription, DNA-templated | 16.25% (39/240) | 1.19 | 1e-06 | 1.2e-05 |
GO:1903506 | regulation of nucleic acid-templated transcription | 16.25% (39/240) | 1.19 | 1e-06 | 1.2e-05 |
GO:2001141 | regulation of RNA biosynthetic process | 16.25% (39/240) | 1.19 | 1e-06 | 1.2e-05 |
GO:0009941 | chloroplast envelope | 7.5% (18/240) | 1.95 | 1e-06 | 1.4e-05 |
GO:0032787 | monocarboxylic acid metabolic process | 12.5% (30/240) | 1.4 | 1e-06 | 1.4e-05 |
GO:0051252 | regulation of RNA metabolic process | 16.25% (39/240) | 1.18 | 1e-06 | 1.5e-05 |
GO:0019752 | carboxylic acid metabolic process | 15.42% (37/240) | 1.22 | 1e-06 | 1.5e-05 |
GO:0009526 | plastid envelope | 7.5% (18/240) | 1.94 | 1e-06 | 1.5e-05 |
GO:0031967 | organelle envelope | 7.92% (19/240) | 1.86 | 2e-06 | 1.6e-05 |
GO:0031975 | envelope | 7.92% (19/240) | 1.86 | 2e-06 | 1.6e-05 |
GO:0008283 | cell proliferation | 4.17% (10/240) | 2.84 | 2e-06 | 1.7e-05 |
GO:0010050 | vegetative phase change | 2.92% (7/240) | 3.61 | 2e-06 | 1.8e-05 |
GO:0043436 | oxoacid metabolic process | 15.83% (38/240) | 1.18 | 2e-06 | 1.9e-05 |
GO:0006082 | organic acid metabolic process | 15.83% (38/240) | 1.18 | 2e-06 | 1.9e-05 |
GO:1901987 | regulation of cell cycle phase transition | 2.92% (7/240) | 3.57 | 2e-06 | 2.2e-05 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 2.92% (7/240) | 3.57 | 2e-06 | 2.2e-05 |
GO:0016246 | RNA interference | 2.92% (7/240) | 3.57 | 2e-06 | 2.2e-05 |
GO:1901564 | organonitrogen compound metabolic process | 26.67% (64/240) | 0.83 | 2e-06 | 2.2e-05 |
GO:0010073 | meristem maintenance | 2.92% (7/240) | 3.55 | 2e-06 | 2.4e-05 |
GO:0031323 | regulation of cellular metabolic process | 18.33% (44/240) | 1.05 | 3e-06 | 2.7e-05 |
GO:0010075 | regulation of meristem growth | 4.17% (10/240) | 2.75 | 3e-06 | 2.7e-05 |
GO:0006275 | regulation of DNA replication | 3.75% (9/240) | 2.95 | 3e-06 | 2.7e-05 |
GO:0006629 | lipid metabolic process | 12.5% (30/240) | 1.35 | 3e-06 | 2.8e-05 |
GO:0006260 | DNA replication | 5.0% (12/240) | 2.41 | 3e-06 | 3.2e-05 |
GO:1901360 | organic cyclic compound metabolic process | 23.33% (56/240) | 0.89 | 3e-06 | 3.2e-05 |
GO:0044255 | cellular lipid metabolic process | 11.25% (27/240) | 1.43 | 3e-06 | 3.2e-05 |
GO:0007346 | regulation of mitotic cell cycle | 3.33% (8/240) | 3.16 | 3e-06 | 3.2e-05 |
GO:0048037 | cofactor binding | 3.33% (8/240) | 3.15 | 4e-06 | 3.5e-05 |
GO:0006725 | cellular aromatic compound metabolic process | 22.5% (54/240) | 0.9 | 4e-06 | 3.5e-05 |
GO:0048449 | floral organ formation | 3.75% (9/240) | 2.89 | 4e-06 | 3.7e-05 |
GO:0019222 | regulation of metabolic process | 19.58% (47/240) | 0.99 | 4e-06 | 3.7e-05 |
GO:0009150 | purine ribonucleotide metabolic process | 5.42% (13/240) | 2.24 | 5e-06 | 4.3e-05 |
GO:0048509 | regulation of meristem development | 4.58% (11/240) | 2.5 | 5e-06 | 4.3e-05 |
GO:0072521 | purine-containing compound metabolic process | 5.83% (14/240) | 2.12 | 5e-06 | 4.6e-05 |
GO:0031048 | chromatin silencing by small RNA | 3.33% (8/240) | 3.0 | 8e-06 | 7e-05 |
GO:0016129 | phytosteroid biosynthetic process | 3.33% (8/240) | 2.99 | 8e-06 | 7.4e-05 |
GO:0016132 | brassinosteroid biosynthetic process | 3.33% (8/240) | 2.99 | 8e-06 | 7.4e-05 |
GO:0009108 | coenzyme biosynthetic process | 5.42% (13/240) | 2.14 | 1e-05 | 8.7e-05 |
GO:0032501 | multicellular organismal process | 14.58% (35/240) | 1.13 | 1e-05 | 9.3e-05 |
GO:0090304 | nucleic acid metabolic process | 15.42% (37/240) | 1.09 | 1.1e-05 | 9.4e-05 |
GO:0044446 | intracellular organelle part | 20.83% (50/240) | 0.89 | 1.1e-05 | 9.8e-05 |
GO:0016128 | phytosteroid metabolic process | 3.33% (8/240) | 2.93 | 1.1e-05 | 9.8e-05 |
GO:0016131 | brassinosteroid metabolic process | 3.33% (8/240) | 2.93 | 1.1e-05 | 9.8e-05 |
GO:0006163 | purine nucleotide metabolic process | 5.42% (13/240) | 2.11 | 1.2e-05 | 0.000101 |
GO:0010608 | posttranscriptional regulation of gene expression | 3.75% (9/240) | 2.7 | 1.2e-05 | 0.000101 |
GO:0009855 | determination of bilateral symmetry | 3.33% (8/240) | 2.92 | 1.2e-05 | 0.000101 |
GO:0044422 | organelle part | 20.83% (50/240) | 0.89 | 1.2e-05 | 0.000101 |
GO:0009799 | specification of symmetry | 3.33% (8/240) | 2.91 | 1.3e-05 | 0.000106 |
GO:0003989 | acetyl-CoA carboxylase activity | 1.25% (3/240) | 5.85 | 1.3e-05 | 0.000107 |
GO:0016126 | sterol biosynthetic process | 3.75% (9/240) | 2.66 | 1.4e-05 | 0.000119 |
GO:0016746 | transferase activity, transferring acyl groups | 4.17% (10/240) | 2.47 | 1.5e-05 | 0.000126 |
GO:0044424 | intracellular part | 82.08% (197/240) | 0.22 | 1.8e-05 | 0.000148 |
GO:0043231 | intracellular membrane-bounded organelle | 72.92% (175/240) | 0.28 | 1.8e-05 | 0.000149 |
GO:0016125 | sterol metabolic process | 3.75% (9/240) | 2.6 | 2e-05 | 0.00016 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 2.5% (6/240) | 3.43 | 2e-05 | 0.000161 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 2.5% (6/240) | 3.43 | 2e-05 | 0.000161 |
GO:0005488 | binding | 32.92% (79/240) | 0.63 | 2e-05 | 0.000162 |
GO:0043227 | membrane-bounded organelle | 72.92% (175/240) | 0.28 | 2.1e-05 | 0.000166 |
GO:0044260 | cellular macromolecule metabolic process | 22.92% (55/240) | 0.81 | 2.1e-05 | 0.000167 |
GO:0051186 | cofactor metabolic process | 9.17% (22/240) | 1.45 | 2.1e-05 | 0.000169 |
GO:0016421 | CoA carboxylase activity | 1.25% (3/240) | 5.63 | 2.2e-05 | 0.000173 |
GO:0016885 | ligase activity, forming carbon-carbon bonds | 1.25% (3/240) | 5.63 | 2.2e-05 | 0.000173 |
GO:0019207 | kinase regulator activity | 2.08% (5/240) | 3.85 | 2.4e-05 | 0.00019 |
GO:0048580 | regulation of post-embryonic development | 6.25% (15/240) | 1.83 | 2.5e-05 | 0.000194 |
GO:0010564 | regulation of cell cycle process | 3.33% (8/240) | 2.73 | 3e-05 | 0.000235 |
GO:0048638 | regulation of developmental growth | 4.58% (11/240) | 2.19 | 3.3e-05 | 0.000258 |
GO:0044281 | small molecule metabolic process | 18.33% (44/240) | 0.9 | 3.5e-05 | 0.000267 |
GO:0043229 | intracellular organelle | 72.92% (175/240) | 0.26 | 4.8e-05 | 0.000368 |
GO:0044428 | nuclear part | 6.67% (16/240) | 1.68 | 5e-05 | 0.000373 |
GO:0043226 | organelle | 72.92% (175/240) | 0.26 | 4.9e-05 | 0.000374 |
GO:0044267 | cellular protein metabolic process | 15.0% (36/240) | 1.0 | 4.9e-05 | 0.000375 |
GO:0009507 | chloroplast | 22.92% (55/240) | 0.76 | 5.1e-05 | 0.000379 |
GO:0006743 | ubiquinone metabolic process | 1.67% (4/240) | 4.26 | 5.1e-05 | 0.00038 |
GO:0006744 | ubiquinone biosynthetic process | 1.67% (4/240) | 4.26 | 5.1e-05 | 0.00038 |
GO:1905393 | plant organ formation | 3.75% (9/240) | 2.42 | 5.3e-05 | 0.000392 |
GO:0042335 | cuticle development | 2.08% (5/240) | 3.59 | 6e-05 | 0.000438 |
GO:1901576 | organic substance biosynthetic process | 23.75% (57/240) | 0.73 | 6.9e-05 | 0.000504 |
GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity | 0.83% (2/240) | 6.85 | 7.5e-05 | 0.00053 |
GO:0019171 | 3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity | 0.83% (2/240) | 6.85 | 7.5e-05 | 0.00053 |
GO:0061062 | regulation of nematode larval development | 0.83% (2/240) | 6.85 | 7.5e-05 | 0.00053 |
GO:0006086 | acetyl-CoA biosynthetic process from pyruvate | 0.83% (2/240) | 6.85 | 7.5e-05 | 0.00053 |
GO:0033597 | mitotic checkpoint complex | 0.83% (2/240) | 6.85 | 7.5e-05 | 0.00053 |
GO:0009374 | biotin binding | 0.83% (2/240) | 6.85 | 7.5e-05 | 0.00053 |
GO:0051052 | regulation of DNA metabolic process | 3.75% (9/240) | 2.35 | 7.5e-05 | 0.00053 |
GO:0080188 | RNA-directed DNA methylation | 1.25% (3/240) | 5.11 | 7.4e-05 | 0.000538 |
GO:0009909 | regulation of flower development | 5.0% (12/240) | 1.95 | 7.8e-05 | 0.000544 |
GO:0003006 | developmental process involved in reproduction | 13.75% (33/240) | 1.03 | 7.8e-05 | 0.000546 |
GO:0006261 | DNA-dependent DNA replication | 3.75% (9/240) | 2.34 | 8.1e-05 | 0.000563 |
GO:0040008 | regulation of growth | 4.58% (11/240) | 2.05 | 8.2e-05 | 0.000564 |
GO:0009536 | plastid | 22.92% (55/240) | 0.73 | 8.6e-05 | 0.000592 |
GO:2000026 | regulation of multicellular organismal development | 6.25% (15/240) | 1.66 | 9.5e-05 | 0.000646 |
GO:0000038 | very long-chain fatty acid metabolic process | 2.08% (5/240) | 3.44 | 9.6e-05 | 0.000656 |
GO:0050794 | regulation of cellular process | 23.75% (57/240) | 0.71 | 9.8e-05 | 0.000664 |
GO:2000241 | regulation of reproductive process | 5.42% (13/240) | 1.81 | 0.000104 | 0.000699 |
GO:0048856 | anatomical structure development | 13.33% (32/240) | 1.02 | 0.000107 | 0.000719 |
GO:0043170 | macromolecule metabolic process | 26.67% (64/240) | 0.65 | 0.00011 | 0.000737 |
GO:0006694 | steroid biosynthetic process | 3.75% (9/240) | 2.26 | 0.000121 | 0.000805 |
GO:0010440 | stomatal lineage progression | 2.08% (5/240) | 3.36 | 0.000126 | 0.000829 |
GO:0048366 | leaf development | 3.33% (8/240) | 2.44 | 0.000125 | 0.000831 |
GO:0009058 | biosynthetic process | 23.75% (57/240) | 0.68 | 0.000155 | 0.001021 |
GO:0051239 | regulation of multicellular organismal process | 6.25% (15/240) | 1.6 | 0.000157 | 0.001027 |
GO:0009259 | ribonucleotide metabolic process | 5.42% (13/240) | 1.74 | 0.000159 | 0.001035 |
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 1.67% (4/240) | 3.85 | 0.000164 | 0.001065 |
GO:0048831 | regulation of shoot system development | 5.0% (12/240) | 1.81 | 0.000186 | 0.001201 |
GO:0044459 | plasma membrane part | 3.75% (9/240) | 2.17 | 0.000194 | 0.001245 |
GO:0006768 | biotin metabolic process | 0.83% (2/240) | 6.26 | 0.000224 | 0.001425 |
GO:0009102 | biotin biosynthetic process | 0.83% (2/240) | 6.26 | 0.000224 | 0.001425 |
GO:0022414 | reproductive process | 15.0% (36/240) | 0.89 | 0.000226 | 0.001433 |
GO:0005634 | nucleus | 44.58% (107/240) | 0.41 | 0.000228 | 0.001443 |
GO:0008202 | steroid metabolic process | 3.75% (9/240) | 2.1 | 0.000282 | 0.001775 |
GO:0044272 | sulfur compound biosynthetic process | 5.42% (13/240) | 1.65 | 0.000292 | 0.001807 |
GO:0019887 | protein kinase regulator activity | 1.67% (4/240) | 3.64 | 0.000292 | 0.001812 |
GO:1901661 | quinone metabolic process | 1.67% (4/240) | 3.64 | 0.000292 | 0.001812 |
GO:1901663 | quinone biosynthetic process | 1.67% (4/240) | 3.64 | 0.000292 | 0.001812 |
GO:0042181 | ketone biosynthetic process | 1.67% (4/240) | 3.6 | 0.000324 | 0.001995 |
GO:0033293 | monocarboxylic acid binding | 1.25% (3/240) | 4.43 | 0.000332 | 0.00204 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 4.17% (10/240) | 1.92 | 0.000349 | 0.002132 |
GO:0048451 | petal formation | 2.08% (5/240) | 3.0 | 0.000412 | 0.002494 |
GO:0048453 | sepal formation | 2.08% (5/240) | 3.0 | 0.000412 | 0.002494 |
GO:0009106 | lipoate metabolic process | 1.67% (4/240) | 3.49 | 0.000435 | 0.002628 |
GO:0004148 | dihydrolipoyl dehydrogenase activity | 0.83% (2/240) | 5.85 | 0.000445 | 0.002675 |
GO:0005515 | protein binding | 14.17% (34/240) | 0.87 | 0.00045 | 0.002696 |
GO:1902275 | regulation of chromatin organization | 1.25% (3/240) | 4.26 | 0.000478 | 0.002853 |
GO:0006796 | phosphate-containing compound metabolic process | 12.5% (30/240) | 0.92 | 0.000568 | 0.003371 |
GO:0048827 | phyllome development | 4.17% (10/240) | 1.83 | 0.000573 | 0.003392 |
GO:0044249 | cellular biosynthetic process | 20.83% (50/240) | 0.66 | 0.000593 | 0.003494 |
GO:0043603 | cellular amide metabolic process | 5.42% (13/240) | 1.53 | 0.000635 | 0.003711 |
GO:1902494 | catalytic complex | 5.42% (13/240) | 1.53 | 0.000635 | 0.003711 |
GO:0006793 | phosphorus metabolic process | 12.5% (30/240) | 0.91 | 0.000689 | 0.004014 |
GO:0004742 | dihydrolipoyllysine-residue acetyltransferase activity | 0.83% (2/240) | 5.53 | 0.000737 | 0.004228 |
GO:0016418 | S-acetyltransferase activity | 0.83% (2/240) | 5.53 | 0.000737 | 0.004228 |
GO:0019842 | vitamin binding | 0.83% (2/240) | 5.53 | 0.000737 | 0.004228 |
GO:0051188 | cofactor biosynthetic process | 5.42% (13/240) | 1.51 | 0.000731 | 0.004242 |
GO:0044451 | nucleoplasm part | 2.5% (6/240) | 2.48 | 0.000764 | 0.004349 |
GO:0010014 | meristem initiation | 2.92% (7/240) | 2.24 | 0.000763 | 0.00436 |
GO:0007389 | pattern specification process | 4.17% (10/240) | 1.77 | 0.000811 | 0.004598 |
GO:0009825 | multidimensional cell growth | 2.08% (5/240) | 2.78 | 0.000835 | 0.004716 |
GO:0006996 | organelle organization | 9.58% (23/240) | 1.05 | 0.000839 | 0.004719 |
GO:0045087 | innate immune response | 5.42% (13/240) | 1.48 | 0.000883 | 0.004953 |
GO:0019538 | protein metabolic process | 16.67% (40/240) | 0.73 | 0.000935 | 0.005221 |
GO:0006955 | immune response | 5.42% (13/240) | 1.47 | 0.000977 | 0.005438 |
GO:0004738 | pyruvate dehydrogenase activity | 0.83% (2/240) | 5.26 | 0.001099 | 0.006007 |
GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity | 0.83% (2/240) | 5.26 | 0.001099 | 0.006007 |
GO:0030523 | dihydrolipoamide S-acyltransferase activity | 0.83% (2/240) | 5.26 | 0.001099 | 0.006007 |
GO:0000791 | euchromatin | 0.83% (2/240) | 5.26 | 0.001099 | 0.006007 |
GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines | 0.83% (2/240) | 5.26 | 0.001099 | 0.006007 |
GO:0002376 | immune system process | 6.25% (15/240) | 1.32 | 0.001164 | 0.006336 |
GO:0042737 | drug catabolic process | 2.5% (6/240) | 2.32 | 0.00133 | 0.007213 |
GO:0006396 | RNA processing | 6.67% (16/240) | 1.24 | 0.001399 | 0.007559 |
GO:0048285 | organelle fission | 2.08% (5/240) | 2.6 | 0.001451 | 0.007812 |
GO:0031935 | regulation of chromatin silencing | 0.83% (2/240) | 5.04 | 0.00153 | 0.008182 |
GO:0016417 | S-acyltransferase activity | 0.83% (2/240) | 5.04 | 0.00153 | 0.008182 |
GO:0006766 | vitamin metabolic process | 2.08% (5/240) | 2.56 | 0.001665 | 0.00887 |
GO:1990234 | transferase complex | 3.33% (8/240) | 1.86 | 0.001773 | 0.009414 |
GO:0005575 | cellular_component | 94.58% (227/240) | 0.09 | 0.001969 | 0.010417 |
GO:0042304 | regulation of fatty acid biosynthetic process | 0.83% (2/240) | 4.85 | 0.002029 | 0.010695 |
GO:0000280 | nuclear division | 1.67% (4/240) | 2.87 | 0.002207 | 0.011591 |
GO:0009117 | nucleotide metabolic process | 6.25% (15/240) | 1.2 | 0.002463 | 0.012889 |
GO:2001251 | negative regulation of chromosome organization | 0.83% (2/240) | 4.68 | 0.002594 | 0.013252 |
GO:0005677 | chromatin silencing complex | 0.83% (2/240) | 4.68 | 0.002594 | 0.013252 |
GO:0017053 | transcriptional repressor complex | 0.83% (2/240) | 4.68 | 0.002594 | 0.013252 |
GO:0090568 | nuclear transcriptional repressor complex | 0.83% (2/240) | 4.68 | 0.002594 | 0.013252 |
GO:0006753 | nucleoside phosphate metabolic process | 6.25% (15/240) | 1.2 | 0.002557 | 0.013291 |
GO:0031226 | intrinsic component of plasma membrane | 2.08% (5/240) | 2.42 | 0.002549 | 0.013295 |
GO:0007020 | microtubule nucleation | 1.67% (4/240) | 2.8 | 0.002616 | 0.013323 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 6.67% (16/240) | 1.15 | 0.002572 | 0.013324 |
GO:0031406 | carboxylic acid binding | 1.25% (3/240) | 3.43 | 0.002659 | 0.013355 |
GO:0043177 | organic acid binding | 1.25% (3/240) | 3.43 | 0.002659 | 0.013355 |
GO:0016444 | somatic cell DNA recombination | 1.25% (3/240) | 3.43 | 0.002659 | 0.013355 |
GO:0019693 | ribose phosphate metabolic process | 5.42% (13/240) | 1.3 | 0.002683 | 0.013435 |
GO:0000096 | sulfur amino acid metabolic process | 3.75% (9/240) | 1.64 | 0.002648 | 0.013435 |
GO:0042023 | DNA endoreduplication | 2.08% (5/240) | 2.38 | 0.00287 | 0.014321 |
GO:0046658 | anchored component of plasma membrane | 1.67% (4/240) | 2.76 | 0.002917 | 0.014507 |
GO:0044786 | cell cycle DNA replication | 2.08% (5/240) | 2.36 | 0.002983 | 0.014788 |
GO:0007049 | cell cycle | 2.92% (7/240) | 1.88 | 0.003128 | 0.015456 |
GO:0019217 | regulation of fatty acid metabolic process | 0.83% (2/240) | 4.53 | 0.003224 | 0.015874 |
GO:0008150 | biological_process | 82.08% (197/240) | 0.14 | 0.003656 | 0.017943 |
GO:0048869 | cellular developmental process | 8.33% (20/240) | 0.96 | 0.00372 | 0.0182 |
GO:0003677 | DNA binding | 9.17% (22/240) | 0.9 | 0.003836 | 0.018704 |
GO:0060968 | regulation of gene silencing | 0.83% (2/240) | 4.39 | 0.003918 | 0.018979 |
GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor | 0.83% (2/240) | 4.39 | 0.003918 | 0.018979 |
GO:0009653 | anatomical structure morphogenesis | 7.92% (19/240) | 0.96 | 0.004538 | 0.021912 |
GO:0000418 | RNA polymerase IV complex | 0.83% (2/240) | 4.26 | 0.004674 | 0.022356 |
GO:0006085 | acetyl-CoA biosynthetic process | 0.83% (2/240) | 4.26 | 0.004674 | 0.022356 |
GO:0009956 | radial pattern formation | 0.83% (2/240) | 4.26 | 0.004674 | 0.022356 |
GO:0042546 | cell wall biogenesis | 2.5% (6/240) | 1.94 | 0.004983 | 0.023757 |
GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor | 0.83% (2/240) | 4.15 | 0.005493 | 0.025535 |
GO:0016783 | sulfurtransferase activity | 0.83% (2/240) | 4.15 | 0.005493 | 0.025535 |
GO:0035384 | thioester biosynthetic process | 0.83% (2/240) | 4.15 | 0.005493 | 0.025535 |
GO:0071616 | acyl-CoA biosynthetic process | 0.83% (2/240) | 4.15 | 0.005493 | 0.025535 |
GO:0000287 | magnesium ion binding | 0.83% (2/240) | 4.15 | 0.005493 | 0.025535 |
GO:0006349 | regulation of gene expression by genetic imprinting | 0.83% (2/240) | 4.15 | 0.005493 | 0.025535 |
GO:0071514 | genetic imprinting | 0.83% (2/240) | 4.15 | 0.005493 | 0.025535 |
GO:0010016 | shoot system morphogenesis | 1.67% (4/240) | 2.51 | 0.005461 | 0.025951 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 1.25% (3/240) | 3.04 | 0.005774 | 0.026761 |
GO:0009832 | plant-type cell wall biogenesis | 2.08% (5/240) | 2.12 | 0.006177 | 0.02854 |
GO:0006468 | protein phosphorylation | 5.42% (13/240) | 1.15 | 0.006231 | 0.028702 |
GO:0006281 | DNA repair | 2.92% (7/240) | 1.7 | 0.006261 | 0.028751 |
GO:0008652 | cellular amino acid biosynthetic process | 4.17% (10/240) | 1.35 | 0.006513 | 0.029817 |
GO:0009069 | serine family amino acid metabolic process | 2.92% (7/240) | 1.66 | 0.007098 | 0.032396 |
GO:0019216 | regulation of lipid metabolic process | 1.25% (3/240) | 2.91 | 0.007444 | 0.033871 |
GO:0098542 | defense response to other organism | 6.67% (16/240) | 0.98 | 0.007835 | 0.035544 |
GO:0007142 | male meiosis II | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0004316 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0010240 | plastid pyruvate dehydrogenase complex | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0045254 | pyruvate dehydrogenase complex | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0009899 | ent-kaurene synthase activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0004318 | enoyl-[acyl-carrier-protein] reductase (NADH) activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0005835 | fatty acid synthase complex | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0016631 | enoyl-[acyl-carrier-protein] reductase activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0047450 | crotonoyl-[acyl-carrier-protein] hydratase activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0031936 | negative regulation of chromatin silencing | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0045815 | positive regulation of gene expression, epigenetic | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0060969 | negative regulation of gene silencing | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0009317 | acetyl-CoA carboxylase complex | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0004076 | biotin synthase activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0010376 | stomatal complex formation | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0000821 | regulation of arginine metabolic process | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0010307 | acetylglutamate kinase regulator activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0090368 | regulation of ornithine metabolic process | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:1900079 | regulation of arginine biosynthetic process | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:2000013 | regulation of arginine biosynthetic process via ornithine | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0010081 | regulation of inflorescence meristem growth | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0008710 | 8-amino-7-oxononanoate synthase activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0010234 | anther wall tapetum cell fate specification | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0047632 | agmatine deiminase activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0017057 | 6-phosphogluconolactonase activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0046167 | glycerol-3-phosphate biosynthetic process | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0042973 | glucan endo-1,3-beta-D-glucosidase activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0004848 | ureidoglycolate hydrolase activity | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0035884 | arabinan biosynthetic process | 0.42% (1/240) | 6.85 | 0.008678 | 0.035888 |
GO:0009524 | phragmoplast | 1.25% (3/240) | 2.82 | 0.008865 | 0.036558 |
GO:0033044 | regulation of chromosome organization | 2.08% (5/240) | 2.02 | 0.008091 | 0.036593 |
GO:0005507 | copper ion binding | 2.5% (6/240) | 1.78 | 0.008399 | 0.037874 |
GO:0044427 | chromosomal part | 1.67% (4/240) | 2.32 | 0.00852 | 0.0383 |
GO:0016310 | phosphorylation | 6.25% (15/240) | 0.97 | 0.010315 | 0.042421 |
GO:0003725 | double-stranded RNA binding | 0.83% (2/240) | 3.68 | 0.010471 | 0.042712 |
GO:1901681 | sulfur compound binding | 0.83% (2/240) | 3.68 | 0.010471 | 0.042712 |
GO:0006546 | glycine catabolic process | 1.25% (3/240) | 2.73 | 0.010434 | 0.042792 |
GO:0009071 | serine family amino acid catabolic process | 1.25% (3/240) | 2.68 | 0.011563 | 0.046911 |
GO:0042135 | neurotransmitter catabolic process | 1.25% (3/240) | 2.68 | 0.011563 | 0.046911 |
GO:0000790 | nuclear chromatin | 0.83% (2/240) | 3.6 | 0.011637 | 0.047081 |
GO:0007154 | cell communication | 4.17% (10/240) | 1.21 | 0.012143 | 0.048997 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 3.75% (9/240) | 1.29 | 0.012371 | 0.049782 |